Tuesday's approval makes Abrysvo the first RSV vaccine indicated for adults younger than 50, the biopharmaceutical company said. Last year, it was approved for use by those 60 years and older, as well ...
A coalition of 21 advocacy groups is pushing for ACIP, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, to lower the age-based recommendation for ...